Contineum Therapeutics, Inc. Class A Common Stock Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| JOHNSON & JOHNSON | 02/13/2025 | 1.98 M | $28.99 M | 0.00% | 10.23% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 02/14/2025 | 1.72 M | $25.20 M | 0.00% | 8.89% |
| FRANKLIN RESOURCES INC | 02/12/2025 | 1.45 M | $21.18 M | -0.14% | 7.47% |
| PERCEPTIVE ADVISORS LLC | 02/14/2025 | 1.44 M | $21.11 M | -4.97% | 7.45% |
| VERSANT VENTURE MANAGEMENT, LLC | 02/12/2025 | 918,163 | $13.45 M | 0.00% | 4.74% |
| VANGUARD GROUP INC | 02/11/2025 | 809,083 | $11.85 M | 75.38% | 4.18% |
| SECTORAL ASSET MANAGEMENT INC | 02/14/2025 | 800,787 | $11.73 M | -0.01% | 4.14% |
| FMR LLC | 02/13/2025 | 691,881 | $10.14 M | -0.72% | 3.58% |
| HHLR ADVISORS, LTD. | 02/14/2025 | 669,337 | $9.81 M | 0.00% | 3.46% |
| 02/14/2025 | 638,158 | $9.35 M | 100.00% | 3.30% | |
| BLACKROCK, INC. | 02/07/2025 | 603,577 | $8.84 M | 49.12% | 3.12% |
| SAMSARA BIOCAPITAL, LLC | 02/14/2025 | 588,816 | $8.63 M | 0.00% | 3.04% |
| SATURN V CAPITAL MANAGEMENT LLC | 02/14/2025 | 573,022 | $8.39 M | 641.33% | 2.96% |
| ALTIUM CAPITAL MANAGEMENT LP | 02/13/2025 | 334,000 | $4.89 M | -9.52% | 1.73% |
| BAKER BROS. ADVISORS LP | 02/14/2025 | 312,500 | $4.58 M | 0.00% | 1.61% |
| CASDIN CAPITAL, LLC | 02/14/2025 | 296,666 | $4.35 M | 0.00% | 1.53% |
| STEMPOINT CAPITAL LP | 02/14/2025 | 265,833 | $3.89 M | 100.00% | 1.37% |
| SQUAREPOINT OPS LLC | 02/14/2025 | 217,239 | $3.18 M | -37.93% | 1.12% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 02/14/2025 | 200,000 | $2.93 M | 0.00% | 1.03% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/12/2025 | 188,408 | $2.76 M | 46.42% | 0.97% |
| NORGES BANK | 02/12/2025 | 169,729 | $2.49 M | 100.00% | 0.88% |
| SCHONFELD STRATEGIC ADVISORS LLC | 02/14/2025 | 125,995 | $1.85 M | 100.00% | 0.65% |
| NORTHERN TRUST CORP | 02/14/2025 | 89,262 | $1.31 M | 42.33% | 0.46% |
| ADAR1 CAPITAL MANAGEMENT, LLC | 02/13/2025 | 82,234 | $1.20 M | 817.07% | 0.42% |
| JANUS HENDERSON GROUP PLC | 02/14/2025 | 68,320 | $1.00 M | 100.00% | 0.35% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 02/06/2025 | 55,330 | $810,585 | 27.80% | 0.29% |
| POLAR CAPITAL HOLDINGS PLC | 02/14/2025 | 43,604 | $638,799 | -79.87% | 0.23% |
| WINTON GROUP LTD | 02/12/2025 | 39,738 | $582,162 | 256.84% | 0.21% |
| MORGAN STANLEY | 02/14/2025 | 26,556 | $389,046 | 30.20% | 0.14% |
| GOLDMAN SACHS GROUP INC | 02/11/2025 | 26,365 | $386,247 | 100.00% | 0.14% |
| STRATEGIES WEALTH ADVISORS, LLC | 02/13/2025 | 25,000 | $206,250 | 100.00% | 0.13% |
| BARCLAYS PLC | 02/13/2025 | 16,286 | $239,000 | 96.03% | 0.08% |
| NUVEEN ASSET MANAGEMENT, LLC | 02/14/2025 | 13,307 | $194,948 | 100.00% | 0.07% |
| MARSHALL WACE, LLP | 02/13/2025 | 10,836 | $158,748 | 100.00% | 0.06% |
| BANK OF AMERICA CORP /DE/ | 02/14/2025 | 9,132 | $133,783 | 63.36% | 0.05% |
| CITIGROUP INC | 02/12/2025 | 8,277 | $121,258 | 69.54% | 0.04% |
| RHUMBLINE ADVISERS | 01/30/2025 | 8,233 | $120,606 | 36.26% | 0.04% |
| MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 02/14/2025 | 5,860 | $85,849 | 90.45% | 0.03% |
| COREBRIDGE FINANCIAL, INC. | 02/11/2025 | 5,215 | $76,400 | 73.08% | 0.03% |
| LEGAL & GENERAL GROUP PLC | 02/13/2025 | 3,631 | $53,194 | 73.98% | 0.02% |
| 02/11/2025 | 1,396 | $20,451 | 100.00% | 0.01% | |
| TOWER RESEARCH CAPITAL LLC (TRC) | 02/13/2025 | 943 | $13,815 | 96.46% | 0.00% |
| AMERITAS INVESTMENT PARTNERS, INC. | 02/13/2025 | 680 | $9,962 | 0.00% | 0.00% |
| NEW YORK STATE COMMON RETIREMENT FUND | 01/31/2025 | 600 | $9,000 | 0.00% | 0.00% |
| AMALGAMATED BANK | 02/04/2025 | 240 | $4,000 | 0.00% | 0.00% |
| HARBOR CAPITAL ADVISORS, INC. | 01/10/2025 | 166 | $2,000 | -1.19% | 0.00% |
| GAMMA INVESTING LLC | 01/03/2025 | 80 | $1,172 | 100.00% | 0.00% |
| STERLING CAPITAL MANAGEMENT LLC | 02/13/2025 | 78 | $1,143 | 500.00% | 0.00% |
| NISA INVESTMENT ADVISORS, LLC | 01/17/2025 | 31 | $454 | 6.90% | 0.00% |
| EVERSOURCE WEALTH ADVISORS, LLC | 02/10/2025 | 3 | $44 | 100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Contineum Therapeutics, Inc. Class A Common Stock institutional Ownership - FAQ's
During the previous two years, 50 institutional investors and hedge funds held shares of Contineum Therapeutics, Inc. Class A Common Stock. The most heavily invested institutionals were:
JOHNSON & JOHNSON: 1.98 M
SUVRETTA CAPITAL MANAGEMENT, LLC: 1.72 M
FRANKLIN RESOURCES INC: 1.45 M
PERCEPTIVE ADVISORS LLC: 1.44 M
Versant Venture Management, LLC: 918,163
VANGUARD GROUP INC: 809,083
80.91% of Contineum Therapeutics, Inc. Class A Common Stock stock is owned by institutional investors.
Institutional investors have bought a total of 15.28 M shares in the last 24 months. This purchase volume represents approximately $72.12 M in transactions.